Valius Sciences

Valius Sciences

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.valiussciences.com/

Last Round

Seed

Apr 13, 2026

Company Overview

Valius Sciences is a biotechnology company that provides multi-omic testing and a bioinformatics platform to generate comprehensive molecular profiles for personalized cancer treatment planning.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Healthcare Analytics, Medical AI, Patient Engagement

Business Model

B2B2C

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

precision oncologymulti-omicsmolecular profilingcancer diagnosticspersonalized cancer therapytumor sequencingnext-generation sequencingbioinformaticsproteomicsgenomicstranscriptomicspatient data platformdirect-to-patient diagnosticsDTC diagnosticsoncology AIscientific advisory services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Valius Sciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Valius Sciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedApr 13, 2026

Valius Sciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 13, 2026

    $10M round completed.

Valius Sciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Valius Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Valius Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2025
Last FundingApr 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.